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Abstract
Phylogenomic analysis of SARS-CoV-2 as available from publicly available repositories suggests the
presence of 3 prevalent groups of viral episomes (super-clades), which are mostly associated with
outbreaks  in  distinct  geographic  locations  (China,  USA and  Europe).  While  levels  of  genomic
variability between SARS-CoV-2 isolates are limited, to our knowledge, it is not clear whether the
observed patterns of variability in viral super-clades reflect ongoing adaptation of SARS-CoV-2, or
merely genetic drift and founder effects.  Here, we analyze more than 1100 complete, high quality
SARS-CoV-2  genome  sequences,  and  provide  evidence  for  the  absence  of  distinct  evolutionary
patterns/signatures  in  the  genomes  of  the  currently  known  major  clades  of   SARS-CoV-2.  Our
analyses suggest  that  the presence of distinct  viral  episomes at  different  geographic locations are
consistent with founder effects, coupled with the rapid spread of this novel virus. We observe that
while  cross  species  adaptation of  the  virus  is  associated with hypervariability  of  specific  protein
coding regions (including the RDB domain of the spike protein), the more variable genomic regions
between extant SARS-CoV-2 episomes correspond with the 3’ and 5’ UTRs, suggesting that at present
viral  protein coding genes should not be subjected to different  adaptive evolutionary pressures in
different  viral  strains.  Although  this  study  can  not  be  conclusive,  we  believe  that  the  evidence
presented here is strongly consistent with the notion that the biased geographic distribution of SARS-
CoV-2 isolates should not be associated with adaptive evolution of this novel pathogen.
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Introduction
The  SARS-CoV-2  pandemic  (Poon  and  Peiris,  2020)  poses  the  greatest  global  health  and
socioeconomic threat  since the second world war. Complete genomic sequences of viral isolates from
diverse geographic sites,  have rapidly been made available through dedicated resources (Shu and
McCauley, 2017, Goodacre et al,2018) facilitating comparative genomics studies, identification of
putative therapeutic targets (Zhou et al, 2020, Chen et al 2020, Robson 2020) and the development of
effective prevention and monitoring strategies (Qiang et  al  2020).  Analyses of available genomic
sequences, according to GISAID EpiCoV, suggest  major viral clades, S, V and G which, collectively,
circumscribe more than 69% of the characterised isolates. Strikingly, these clades show a markedly
biased prevalence in different  areas,  with the S clade accounting for more than 72% of the viral
isolates characterized in the USA, and the G clade comprising more than 74% of those that have been
sequenced in Europe.
Importantly, while the G-clade was initially considered to be composed of viral strains which were not
observed in China, availability of additional genomic sequences suggests that this clade as well should
be  nested  within  isolates  from  Shanghai.  Although  comparative  analyses  suggest  that  genomic
variability between different isolates of  SARS-CoV-2 is generally low (Lu et al, 2020, Zhang e t al,
2020,  Tang  et  al,  2020),  the  fact  that  distinct  viral  episomes  show  a  highly  biased  geographic
distribution is potentially alarming, as, at present, it is not completely clear whether frequent variants
reflect the adaptive processes, which result in the emergence of novel, and potentially more virulent
strains. Moreover at present it is unclear whether the genomic variability of major clades of  SARS-
CoV-2 and their biased geographic distribution, could explain -at least in part- apparent differing rates
of lethality observed worldwide (Baud et al 2020).
In the present study, exploiting curated viral genomic sequences, we present analyses of more than
1100 complete SARS-CoV-2 genomes, identified from 5 continents and more than 45 countries. By
contrasting evolutionary patterns associated with the most prevalent viral clades, with those observed
between  closely  related  viral  strains  isolated  from  various  species,  we  provide  insights  into  the
evolutionary  dynamics  and  adaptation  of  SARS-CoV-2  like  viruses  to  different  hosts  and  the
evolutionary patterns of the major clades of SARS-CoV-2. 
We show that while the majority of the genomic variants that discriminate between major viral clades
cause  non synonymous  substitutions  in  protein  coding  genes,  including  genes   implicated in  the
modulation of the virulence of SARS-CoV-2  such as  the spike protein and the RNA dependent
polymerase (Weiss and Navas-Martin, 2005), the major clades of SARS-CoV-2 show nearly identical
patterns of genomic variability as well as the absence of signatures that are normally associated with
adaptive evolution at protein coding loci. Indeed, the major clades of SARS-CoV-2 are identified only
by a limited number of clade-specific genetic variants and show very modest variability. Notably,
variable sites are enriched in the 5’ and 3’ non coding regions of the genome, unlike genomic sites
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which are hyper-variable between closely related strains with distinct host specificites.
While  our  observations  cannot  be  considered  conclusive,  we  believe  that  the  available  data  are
broadly consistent with the notion that the biased geographic distribution of SARS-CoV-2 isolates is
not  associated  with  adaptive  evolution  of  this  novel  pathogen,  but  rather  with  extensive  founder
effects coupled with the rapid spread of this pathogen in diverse geographic zones.
Results 
A total of 1113 complete, high quality SARS-CoV-2 genomic sequences, as well as of 2 SARS-CoV-2
like viruses isolated from non-human hosts (bats and pangolins (Zhou et al 2020, Matthew et al 2020),
were  retrieved  from  the  GISAID  EpiCoV  portal  on  March  24th  2020.  Associated  metadata
(Supplementary Table S1) show that these isolates included in cover more than 45 countries in 5
continents. As expected, the geographic distribution of the data closely reflects geographic prevalence
of the pandemic, although notable exceptions include limited public data from Italy, one of the early
hotspots of the pandemic. 
Genomic  sequences  obtained  from GISAID EpiCoV were  aligned to  the  reference  SARS-CoV-2
assembly (Refseq (O'Leary  et  al,  2016) accession NC_045512.2) ,  i.e.,  the presumably ancestral
Wuhan isolate (Wu et al, 2020), and  derive a phenetic matrix of presence/absence of the variants.
Substitution patterns of nucleotide residues, as shown in Supplementary Table S2 and Supplementary
Figure S1, show a clear prevalence of C->T substitutions with respect to the presumably ancestral
Wuhan isolate, with C->T representing 38% of all the observed distinct variants and an almost 4 fold
enrichment of C->T with respect to T->C. Strikingly, the same pattern is not recovered when the
SARS-CoV-2 genome is compared with genomic sequences of closely related viral specimens isolated
from non-human hosts,  suggesting a  specific  error/substitution  pattern  of  the  SARS-CoV-2 RNA
dependent  RNA polymerase.  This  observation  is  confirmed  even  when  only  polymorphic  sites
common  between  2  or  more  genomes  are  considered.  Intriguingly,  analyses  of  the  substitution
patterns of the coronavirus associated with the 2003-2004 SARS outbreak (Chinese SARS Molecular
Epidemiology Consortium, 2004, Song et al 2005) do show a similar, but less marked tendency of
increased C->T substitutions. 
Clustering of viral episomes based on 844 genetic variants present in at least 2 genomes - Fig 1 (see
Materials and methods)- delineates 3 super-clades of viral strains, consistent with the classification of
the isolates proposed by the GISAID EpiCoV portal (Shu and McCauley, 2017). Super-clade I is a
superset of clade V as defined in GISAID, and contains viral sequences that have a limited variability
with  respect  to  the  reference  genome  and  were  isolated  in  Europe  and  Asia.  Super-clade  II
corresponds  with  the  S-clade  as  identified  by  GISAID and  incorporates  viral  isolates  which  are
prevalently from the USA and from China. Finally Super-clade III corresponds with the G-clade as
defined  by  GISAID  and  is  formed  mostly  by  European  sequences.  Therefore,  a  highly  biased
geographic distribution (Figure 1), consistent with previous reports, is observed in all the 3 Super-
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clades. In particular (Figure 1), we notice that isolates from the USA are prevalently associated with
Super-clade II,  while isolates from Europe are prevalent in Super-clade III.  Finally, Super-clade I
incorporates the majority of viral isolates identified in Asia, and a more limited number of European
isolates.  
Overall  our  analyses  confirm the limited variability of the SARS-CoV-2 genome (Supplementary
Figure S2), with an average number of 5.2 polymorphic sites observed between individual isolates
and  the  reference  genome.  As  reported  in  Supplementary  Table  S4,  of  the  983  sites  that  were
polymorphic  in  at  least  1  SARS-CoV-2  genome  considered  in  the  study,  310  (31.5%)  were
synonymous substitutions, 545 (55.4%) non-synonymous substitutions and 115 were associated with
non-coding regions (5’ and 3’ UTR).  Only a very limited number of indels were observed, with 3
single base insertions (2 in the 3’ UTR and 1 in the 5’ UTR) and 12  small insertions of which 10 were
associated with the UTR regions of the genome. 
The majority of polymorphic sites (703/983, 71.15%) are singletons associated with an individual
viral  isolate  (Supplementary  Figure  S3).   Interestingly,  we  notice  that  the  average  number  of
polymorphic sites in SARS-CoV-2 isolates are significantly (Wilcoxon p-value ≤ 1e-05) lower  than
the average variable sites between late-phase isolates of the SARS epidemic of 2003 (Supplementary
Figure S2). Consistent with these reduced levels of variability, we observe that the 3 Super-clades
identified  in  this  study are  defined  by  only  a  limited  number  of  genetic  polymorphic  sites.  For
example,  as  evident  from  Figure  1,  Super-clade  II  is  characterized  by  the  presence  of  only  2
polymorphic sites, which are common and specific to all the isolates of this group (8702 C->T and
28144 C->T). Super-clade III is defined by the presence of only 4 clade-specific variants (241 C->T,
3037 C->T, 14408 C->T and 23403 D->G). While no genetic variants are ubiquitous and exclusively
associated with strains included in Super-clade I.
This notwithstanding we notice the presence of additional genomic variants, which could subtend the
presence of smaller sub-clades.
Consistent with this observation, cluster stability metrics, based on the Dunn index, were strongly
consistent with the presence of 9 clusters in the phenetic matrix of viral isolates. Clustering of viral
isolates,  based on the k-means algorithm with 9 clusters (Figure 1 and Supplementary Table S3)
demonstrates a neat separation of viral episomes, with cluster number 7 corresponding to the two
genome sequences of the SARS-CoV-2 like strains isolated from non human hosts. Cluster number 1
is formed by episomes that have limited variability with respect to the reference genome; cluster 2, 5
and 9 incorporate all the strains included in the European clade G; while clusters 3 and 4 correspond
to the GISAID EpicoV clade S, with cluster 3 containing the majority of viral isolates prevalent in the
U.S. Cluster 6 and cluster 8, which are composed of 35 and 40 viral strains, respectively, corresponds
to a subset of the V clade as described in GISAID EpiCoV. While the majority of isolates included in
cluster  8 have been isolated in Europe,  cluster  6 does not  seem to be associated with a  specific
geographic location. Notably, (Table 1 and Supplementary Table S4) we observe that the majority of
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polymorphic sites that discriminate between the 9 clusters identified by our analyses, are associated
with nonsynonymous amino-acid substitutions, and several of these substitutions occur in viral genes
that have been implicated in the modulation of the virulence of SARS and SARS-like associated
coronavirus, including the spike protein and the RNA dependent RNA polymerase (nsp12) (Weiss and
Navas-Martin, 2005). In order to test the possibility that these variations could reflect early hints of
adaptive  evolution  of  SARS-CoV-2  strains,  evolutionary  dynamics  of  viral  super-clades  were
contrasted with  patterns  of  evolution  of  the   two closely  related  viral  strains  with  different  host
specificity.
As  shown  in  Figure  2,  comparison  of  intra-cluster  variability,  performed  using  only  the  713
polymorphic sites that are associated with a single viral isolate, clearly demonstrates similar levels of
variation  between  all  the  SARS-CoV-2  clusters  identified  in  this  study,  with  a  slight  (but  not
statistically significant,  Wilcoxon test p-value 0.129) increase in variability for strains included in
cluster 6.
In order to identify regions of the genome which could be subject to distinct evolutionary pressures,
plots  of  local  genomic  variability   along the  complete  genomic  sequence  of  SARS-CoV-2,  were
prepared by computing the proportion of polymorphic sites identified in each of the viral Super-clades
on sliding genomic windows of 100 bp in size and overlapping by 50 bp. As shown in Figure 3 A-C,
the  observed  patterns  are  remarkably  similar  between  the  3  Super-clades,  suggesting  similar
evolutionary dynamics. Moreover, we note that polymorphic sites are significantly enriched (Adjusted
Fisher test p-value ≤1e-15 and ≤1e-12 respectively) in both the 5’ and 3’ UTR regions, while protein
coding loci show considerably reduced variability.  
Similar analyses performed by comparing the reference SARS-CoV-2 genome with the genomes of
SARS-CoV-2-like coronavirus with a different host specificity, show the presence of a distinct pattern
of variation in SARS-CoV-2-like genomes that is likely the result  of  adaptive evolutionary pressures
(Figure 3 D-E).  Indeed, hyper-variable genomic regions (Adjusted Fisher test p-value ≤1e-10 and
≤1e-5 respectively for comparisons of SARS-CoV-2 like CoVs isolated from bats and pangolins)
between these genomes clearly correspond with protein coding loci, and in particular with the RDB
protein domain of the S1 subunit of the spike protein -  the domain which mediates the recognition of
the host ACE2 receptor (see the peak at around position 23000 in  Figure 3 D-E). A similar pattern is
recovered also when genomes of bat and pangolin SARS-CoV-2 like CoVs are compared (Figure 3 F).
Analyses of dN/dS patterns (Supplementary Table S5) indicate that, as expected, the RDB domain of
the spike protein seems to be subject  to strong diversifying selection between viral  isolates with
different host specificity (dN/dS > 1).  On the contrary, in SARS-CoV-2 isolates we do not observe a
dN/dS value > 1of the RDB domain, but we notice that, in all our comparisons, the gene coding for
the spike protein shows the highest level of dN/dS among all protein coding genes, suggesting that -
probably to facilitate adaptation to different hosts - this gene could be subject to relaxed selective
pressure in coronaviruses. 
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Taken  together,  our  analyses  of  variability  profiles  of  SARS-CoV-2  and  SARS-CoV-2-like
coronaviruses  are consistent with the notion that regions in the genome corresponding with increased
variability,  should  be  associated  with  relaxed  purifying  selection  and/or  increased  diversifying
selection.  In this respect it is interesting to note that the 5’ and 3’ UTRs, which are the most variable
regions of the genome between major SARS-CoV-2 strains, are among the least variable genomic
regions,  when  SARS-CoV-2  and  SARS-CoV-2  like  strains  with  a  different  host  specificity  are
compared. 
Discussion 
Notwithstanding the limited variability of the genome, which prevents more detailed evolutionary
analyses,  our  analyses   provide  no  evidence  for  distinct  evolutionary  constraints  acting  on  the
different  superclades  and  clusters  of  SARS-CoV-2  genomes.  Although  these  results  cannot  be
conclusive, the observation of similar dynamics of genomic variability, and that variable sites are
prevalent at the 3’ and 5’ UTR genomic regions of SARS-CoV-2 indicate that it is unlikely that these
differences should be the result of adaptive selection. 
However,  we  notice  that  in  SARS-CoV-2  the  spike  protein  evolves  under  less  constrained
evolutionary dynamics compared to other genes. Indeed, in spite of the limited number of variable
sites (135/3822) a dN/dS ratio of ~ 0.7 is observed for the spike gene, a value that is well above the
value recovered for genes of similar size in the same genome and that would indicate that the spike
gene is subject to weaker evolutionary constraints than the other protein coding genes. This possibly
reflects a mechanism for the rapid adaptation to a more widespread range of hosts, as for example
suggested by Menachery et al (Menachery et al, 2016).
Notwithstanding some limitations, our comparative analyses are consistent with the hypothesis that
the biased geographic distribution, and the allelic differences observed between major viral SARS-
CoV-2 clades are not the result of an adaptive evolutionary process, but are more consistent with
founder effects on viral populations, coupled with the rapid spread of this novel virus.
Although our analyses do not suggest distinct evolutionary patterns, it remains unclear whether the
genetic variants that discriminate between major viral clades could be related with differences in the
virulence/pathogenicity  of  these  clades.  To address  this  issue  it  will  be  crucial  to  collect  patient
metadata, to sequence more genomes, and to enable the execution of retrospective statistical analyses.
Materials and methods 
The complete collection of high quality, complete SARS-CoV-2 genomes and associated metadata
was accessed from the GISAID EpicoV (Shu and McCauley, 2017) platform on March 24th 2020.
Genomes were aligned to the reference assembly of SARS-CoV-2 as available from Refseq  (O’Leary
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et al 2016); Refseq accession NC_045512.2) by means of the nucmer (Marçais et al, 2018) program. 
Viral genomes of the SARS 2003 outbreak were retrieved from the NCBI virus database (Goodacre et
al, 2018). Classification/association of strains to the 3 (early/middle/late) phases of the epidemic are
according to Song et al 2005. Only isolates from the late phase of the epidemic were considered,
based on considerations regarding the availability of a relatively high number of genomes (65) and the
high level of similarity with the reference SARS-CoV genome. 
Polymorphic sites were identified by using the show-snps utility of the nucmer package. Output files
were processed by the means of a custom Perl script, and incorporated in a phenetic matrix, with
variable positions on the rows and viral isolates in the columns. For all the isolates considered in the
study, values of 1 were used to indicate presence of a variant, values of 0 its absence.
dN/dS rates were computed on aligned CDS sequences using the Ka/Ks calculator tool (Zang et al,
2006) allowing for the selection of the most appropriate substitution model,  based on the Akaike
information criterion. The GY (Goldman and Yang,1994) model resulted to be the preferred model in
all the settings herein tested. Only proteins longer than 100 amino acid residues and with more than
50 polymorphic sites in the CDS, were considered in this analysis. For SARS-CoV-2 this was limited
to nsp12, nsp3, nsp4 and the spike protein. 
Variability  with  respect  to  the  reference  NC_045512.2  SARS-CoV-2 assembly  was  computed  on
sliding windows of 100 bp, overlapped by 50 bp, by counting the proportion  of variable genomic
sites contained in each window (number of variable sites in the window, divided by the total number
of variable sites), by using a custom Perl script. A Fisher-exact test, contrasting the local variability in
a window with the average variability in the genome, was used to identify hypervariable regions. P-
values were corrected using the Benjamini Hochberg procedure for the control of False Discovery
Rate.
Functional effects of genetic variants as identified from genome alignments, were predicted by means
of  a  custom  Perl  script,  based  on  the  annotation  of  the  NC_045512.2  SARS-CoV-2  reference
assembly. 
Graphical representation of the data, basic statistical analyses and clustering of viral isolates were
performed by means of the standard libraries of the R programming language. Similar to previous
studies  for  the  classification  of  SARS-CoV  genomes  (Chinese  SARS  Molecular  Epidemiology
Consortium, Song et al, 2005),  clustering of viral genomes was performed by considering only sites
that  were polymorphic  in  at  least  2  different  genomes.  Singleton sites,  that  is  polymorphic  sites
observed only in one genome, were excluded from this analysis due to considerations regarding the
limited information content, but also to the fact that, according to previous reports, these sites could
be slightly enriched in sequencing errors (Song et al, 2005).  Analogous considerations prompted us to
execute the analysis of substitutions patterns both on the complete collection of polymorphic sites,
and only on sites that were polymorphic in at least 2 genomes. 
Determination of the optimal clustering solution was performed based on the Dunn Index metrics, as
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computed by the clValid R package (Brock et al, 2008).
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Figures and Tables Legends 
Table 1. List of polymorphic sites characteristic of each cluster of SARS-CoV-2 episomes. Position:
indicates the genomic coordinate of the polymorphic site, Reference: the sequence of the reference
genome  and  Alternative:  the  alternative  allele,  respectively.  For  variants  associated  with  protein
coding genes, the “AAresidue” and the “AAchange” columns are used to indicate the affected amino-
acidic residue in protein coordinates and the predicted change in amino acid sequence, “-” indicates a
silent  substitution.  The  Gene  column  reports  the  corresponding  geneor  functionally  annotated
genomic element, while “Number of isolates” indicates the number of viral isolates in each cluster
that have the polymorphism
Figure 1. Heatmap of polymorphic sites in SARS-CoV-2 and SARS-CoV-2 like episomes.  Color
codes  at  the  top  of  the  heatmap  indicate  the  type  (light  blue=substitution,  black=deletion,
purple=insertion) of the 844 genetic variants present in at least 2 distinct viral isolates.  Genomic
coordinates are represented on the X axis. The panels on the left indicate membership of one of
the 9 clusters as defined in the text. Separation between the 3 Super-clades are indicated by red dotted
lines. The panel on the right shows the geographic origin of the isolates (Green=USA, Yellow=China,
not Wuhan, Red=China, Wuhan, Maroon=Australia, Blue=Europe, Orange=Asia, not China, Purple=
South America, Black= non human host). The white boxes on the far right of the same panel represent
the  V,  S  and G clade  as  from the  GISAID portal.  Presence/absence  of  the  polymorphic  sites  is
indicated by a binary color code: Yellow=absent, that is the sequence is identical to the reference
genome at that site, and Red=present. 
Figure 2. Boxplot  of  genomic variability for the 8 viral  clusters of  human-specific SARS-CoV-2
episomes, based on singleton polymorphic sites. Cluster color codes are as in Figure 1.
Figure 3. Plot of genomic variability  calculated as  the proportion of variable sites identified in
overlapping genomic windows of 100 bp in:A) Super-clade I; B) Super-clade II; C) Super-clade III;D)
the comparison of bat RaTG13 SARS-CoV-2 like against the reference SARS-CoV-2 genome; E) the
comparison of Pangolin SARS-CoV-2 like against  the reference SARS-CoV-2;F) the comparison of
bat RaTG13 SARS-CoV-2 like against  the pangolin SARS-CoV-2 like.  Genomic coordinates are
represented on the X axis, number of variable sites per window on the Y axis
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Supplementary Figures and Tables Legends
Supplementary Table S1. List of viral isolates included in the study. The table is in the same format
as the submission acknowledgment table available from the GISAID EpiCoV website. 
Supplementary Table S2. 
Rates of nucleotide substitution as identified from whole genome alignment. For every possible single
nucleotide substitution (rows), the table reports the frequency of that substitution for: SARS-CoV-
2_All  vs SARS-CoV-2: alignments between SARS-CoV-2 genomes;  SARS-Cov-2_2G  vs SARS-
CoV-2: as before , but computed only on polymorphic sites common to at least 2 genomes; SARS
2003L vs SARS 2003: alignment between all the SARS-CoV isolates from the late phase of the SARS
2003 epidemic (SARS 2003L) with the reference SARS-CoV genome; bat RaTG13 CoV vs SARS-
CoV-2: alignment between the SARS-Cov-2 reference genome and the genome of a SARS-Cov-2 like
of  bat(RaTG13  genome);  pangolin  CoV  vs  SARS-CoV-2:  alignment  between  the  SARS-Cov-2
reference genome and the genome of a SARS-Cov-2 like  pangolin
Supplementary Table S3.  Cluster assignment of  viral isolates. Accession number of the isolate in
GISAID and the relative N° of polymorphic sites with respect  to the reference genome, are also
reported
Supplementary Table S4.  Functional  annotation of polymorphic sites.  The table lists all  the 983
polymorphic sites identified from the comparison of 1113 SARS-Cov-2 genomes with the Refseq
assembly. “Pos” reports the genomic coordinates of the polymorphic site, followed by the sequence
on  the  reference  assembly  (Ref)   and  the  alternative  sequence  (Alt),  with  “.”  indicating
insertion/deletions.  For variants associated with protein coding genes, “AA pos” and “AA change”
are used to indicate the affected amino-acidic residue in protein coordinates, and the predicted change
in amino acid sequence, respectively. Type indicates the predicted functional effect:  “S” indicates a
silent substitution, “NS” a nonsynonymous substitution, “FS” a frameshift, “Non-coding”, that the
variant is associated with a non protein coding region of the genome, “Na”, stands for not applicable.
“Functional element” reports the corresponding gene or functionally annotated genomic element, and
“N° of genomes” indicates the number of viral isolates in each cluster that have the polymorphic site.
The equivalent information for every cluster (number of isolates that have the variant) is reported in
the columns “Cluster 1” to “Cluster 9”, for clusters from 1 to 9 respectively.
Supplementary Table S5. dN/dS ratio. The table reports the dN/dS ratio, computed by the means of
the KaKs_Calculator for all the protein coding genes longer than 100 aa residues and with more than
50 variable sites associated with their CDS. Proteins are indicated by their gene symbol on the rows.
“spike_rbd” indicates the spike recognition binding domain, “concat_no_spike”, indicates a supergene
formed by all the protein coding genes in the genome with the exclusion of the spike protein. “Na”
stands for not applicable. bat RaTG13 CoV vs  SARS-CoV-2: dN/dS between SARS-CoV-2 and the
bat RaTG13 CoV; pangolin CoV vs SARS-CoV-2: dN/dS between SARS-CoV-2 and the SARS-CoV-
2 like CoV isolated from pangolin specimens; SARS-CoV-2: dN/dS for SARS-CoV-2.
Supplementary Figure S1.  Heatmap of nucleotide substitution frequencies. The heatmap displays
nucleotide substitution frequencies, as derived from whole genome alignment as reported in Table S1.
Frequencies are reported in each cell of the heatmap. A gray (low) to blue (high) gradient of color is
used.  The  suffix  “_AllG”  and  “_2G”  are  used  to  indicate  substitution  profiles  derived  from the
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analysis of all the variable sites (“_AllG”) or of only sites variable in at least 2 genomes (“_2G”).
Supplementary Figure S2.  Histogram of the number of variable sites identified in: A) any SARS-
CoV-2 genomes included in this study, with respect to the reference SARS-CoV-2 genome; B) SARS
-CoV genomes from the late phase of the 2003 epidemic with respect to the SARS-CoV reference
genome.
Supplementary  Figure  S3.  Prevalence  of  polymorphic  sites  in  viral  isolates.   Number  of  viral
genomes is reported on the X axis. Log scaled counts of the number of polymorphic sites supported
by that number of genomic sequences is indicated on the Y axis
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Table 1
13
position reference alternative AA residue AA change Gene
cluster1
11083 G T 37 L->F nsp6 95
cluster2
241 C T 81 Na 5'UTR 125
3037 C T 106 - nsp3 127
14408 C T 323 P->L nsp12 125
23403 A G 614 D->G spike 127
cluster3
8782 C T 76 - nsp4 246
17747 C T 504 P->L nsp13 246
17858 A G 541 Y->C nsp13 248
18060 C T 7 - nsp14 247
28144 T C 84 L->S orf8 248
cluster4
8782 C T 76 - nsp4 137
28144 T C 84 L->S orf8 138
cluster5
241 C T 81 Na 5'UTR 133
3037 C T 106 - nsp3 133
14408 C T 323 P->L nsp12 133
23403 A G 614 D->G spike 133
28881 GGG AAC 203;204 R->K,G->R geneN 133
cluster6
1397 G A 198 V->I nsp2 35
11083 G T 37 L->F nsp6 34
28688 T C 139 - geneN 35
29742 G T 22 Na 3'UTR 30
cluster8
11083 G T 37 L->F nsp6 32
14805 C T 455 - nsp12 40
17247 T C 337 - nsp13 29
26144 G T 251 G->V orf3A 39
cluster9
241 C T 81 Na 5'UTR 77
1059 C T 85 T->I nsp2 61
3037 C T 106 - nsp3 78
14408 C T 323 P->L nsp12 78
23403 A G 614 D->G spike 78
25563 G T 57 Q->H orf3A 78
Number of 
isolates
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Figure  1. Heatmap  of  polymorphic  sites  in  SARS-CoV-2  and  SARS-CoV-2  like  episomes.  Color  codes  at  the  top  of  the  heatmap  indicate  the  type  (light
blue=substitution, black=deletion, purple=insertion) of the 844 genetic variants present in at least 2 distinct viral isolates. Genomic coordinates are represented on
the X axis. The panels on the left indicate membership of one of the 9 clusters as defined in the text. Separation between the 3 Super-clades are indicated by red
dotted lines. The panel on the right shows the geographic origin of the isolates (Green=USA, Yellow=China, not Wuhan, Red=China, Wuhan, Maroon=Australia,
Blue=Europe, Orange=Asia, not China, Purple= South America, Black= non human host). The white boxes on the far right of the same panel represent the V, S and
G clade as from the GISAID portal. Presence/absence of the polymorphic sites is indicated by a binary color code: Yellow=absent, that is the sequence is identical to
the reference genome at that site, and Red=present. 
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Figure 2. Boxplot of genomic variability for the 8 viral clusters of human-specific SARS-CoV-2 episomes, based on singleton polymorphic sites. Cluster color codes
are as in Figure 1.
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Figure 3. Plot of genomic variability  calculated as  the proportion of variable sites identified in overlapping genomic windows of 100 bp in:A) Super-clade I; B) Super-clade II; C)
Super-clade III;D) the comparison of bat RaTG13 SARS-CoV-2 like against the reference SARS-CoV-2 genome; E) the comparison of Pangolin SARS-CoV-2 like against  the
reference SARS-CoV-2;F) the comparison of  bat RaTG13 SARS-CoV-2 like against  the pangolin SARS-CoV-2 like.  Genomic coordinates are represented on the X axis, number of
variable sites per window on the Y axis
SARS-CoV-2 vs bat RaTG13 CoV SARS-CoV-2 vs Pangolin CoV bat RaTG13 CoV vs Pangolin CoV 
Super-clade I Super-clade II Super-clade III
A) B) C)
D) E) F)
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